Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-14 Reardon Andrew CLO & Secretary Shares withheld for taxes −4,083 $183.83 $751K 39,255
2026-02-14 Espinoza Octavio Chief Financial Officer Grant or award +7,390 35,965
2026-02-14 Espinoza Octavio Chief Financial Officer Shares withheld for taxes −3,761 $183.83 $691K 32,204
2026-02-14 Espinoza Octavio Chief Financial Officer Grant or award +8,810 41,014
2026-02-14 Espinoza Octavio Chief Financial Officer Shares withheld for taxes −4,483 $183.83 $824K 36,531
2026-02-14 Davis Todd C Chief Executive Officer Grant or award +20,782 182,119
2026-02-14 Davis Todd C Chief Executive Officer Shares withheld for taxes −8,178 $183.83 $1.5M 173,941
2026-02-14 Davis Todd C Chief Executive Officer Grant or award +39,644 213,585
2026-02-14 Davis Todd C Chief Executive Officer Shares withheld for taxes −15,600 $183.83 $2.9M 197,985
2026-02-02 KOZARICH JOHN W Director Sale 10b5-1 −39 $191.00 $7K 43,615
2026-02-02 KOZARICH JOHN W Director Sale 10b5-1 −1 $192.18 $192 43,614
2026-02-02 KOZARICH JOHN W Director Sale 10b5-1 −23 $195.61 $4K 43,591
2026-02-02 KOZARICH JOHN W Director Sale 10b5-1 −381 $196.36 $75K 43,210
2026-02-02 KOZARICH JOHN W Director Sale 10b5-1 −23 $197.20 $5K 43,187
2026-01-02 KOZARICH JOHN W Director Sale 10b5-1 −21 $186.59 $4K 44,100
2026-01-02 KOZARICH JOHN W Director Sale 10b5-1 −91 $187.95 $17K 44,009
2026-01-02 KOZARICH JOHN W Director Sale 10b5-1 −102 $188.96 $19K 43,907
2026-01-02 KOZARICH JOHN W Director Sale 10b5-1 −207 $190.27 $39K 43,700
2026-01-02 KOZARICH JOHN W Director Sale 10b5-1 −46 $192.40 $9K 43,654
2025-12-31 Espinoza Octavio Chief Financial Officer Other acquisition +8 $95.68 $765 28,575

Page 12 of 43 · 858 trades